Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,163 $ 1,053
Accounts receivable and contract assets, net of allowance for credit losses of $24 million and $28 million, respectively 210 205
Income taxes receivable 48 1
Other current assets 49 44
Total current assets 1,470 1,303
Property and equipment, net 99 103
Intangible assets not subject to amortization (note 6):    
Goodwill 2,202 2,200
Trademarks 728 726
Intangible assets not subject to amortization 2,930 2,926
Intangible assets subject to amortization, net 114 112
Other assets, at cost, net of accumulated amortization 143 194
Total assets 4,756 4,638
Current liabilities:    
Deferred merchant and other payables 345 242
Deferred revenue 81 44
Accrued liabilities and other current liabilities 338 248
Total current liabilities 764 534
Long-term debt, including $258 million and $237 million measured at fair value as of March 31, 2023 and December 31, 2022, respectively (note 5) 1,146 1,125
Deferred income tax liabilities 125 120
Financial instrument liabilities (note 4) 25 30
Series A Preferred Stock liability (note 6) 235 230
Other liabilities 275 337
Total liabilities 2,570 2,376
Equity:    
Additional paid-in capital 281 287
Accumulated other comprehensive earnings (loss), net of taxes   9
Retained earnings (deficit) (470) (439)
Total stockholders' equity (188) (142)
Noncontrolling interests in equity of subsidiaries 2,374 2,404
Total equity 2,186 2,262
Commitments and contingencies (note 8)
Total liabilities and equity 4,756 4,638
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value